ÂÜÀòÂÒÂ×

Oliver Yasbek, CPA has a diverse work experience in finance and accounting. Oliver is currently serving as the VP of Finance at DICE Therapeutics since January 2022. Prior to that, they worked as the Senior Director of Financial Planning and Analysis at Adamas Pharmaceuticals, Inc. from April 2021 to December 2021. Oliver also has experience as a Senior Director of Finance and Accounting at Custopharm, Inc. from July 2019 to April 2021. Before joining Custopharm, Inc., Oliver worked at Nixon as a Senior Director of Finance and Accounting from April 2019 to July 2019, and as a Corporate Controller from March 2016 to April 2019. Oliver has also held various roles at Digirad, including Vice President of Finance and Corporate Controller from January 2015 to March 2016, and Corporate Controller from January 2013 to December 2014. Oliver's earlier experience includes working at Sapphire Energy Inc. as a Corporate Controller from September 2012 to January 2013, Senior Manager of Accounting and Finance from April 2012 to August 2012, and Manager of Accounting and Finance from November 2010 to March 2012. Oliver began their career at PwC, where they worked as a Manager of Assurance from July 2010 to October 2010, Senior Associate from September 2007 to June 2010, and Associate from September 2004 to August 2007. Oliver has proven expertise in financial planning, analysis, and accounting, gained through their extensive work in various companies.

Oliver Yasbek, CPA, obtained a Bachelor of Science degree in Accounting from the University of Maryland - Robert H. Smith School of Business in the years 2000 to 2004.